Life Sciences

From accelerating drug discovery to leveraging real-world evidence, Centaur.AI provides life science innovators with high-quality data annotations at unprecedented speed and scale.

Trusted by AI leaders from startups to enterprises

Use case

Accelerating drug discovery and development with AI-enabled research and opportunity identification for approved therapies.

Drug Discovery

AI is increasingly used in drug discovery to understand disease mechanisms, and predict response rates.

  • Image analysis

  • Multi-omics and clinical notes

  • Intellectual property knowledge graph

Clinical development

From patient recruitment, to insights on current and past clinical trials, AI offers an opportunity to optimize trial design and success.

  • Predicting patient qualification

  • Real world data analysis

  • Reanalysis of failed clinical trials

  • Patient subgroup identification

Commercial insights

Big data and AI are being leveraged to better understand competitors, as well as HCP behaviors.

  • Improve HCP targeting

  • Competitive analysis

  • Patient identification

  • Predicting adherence

Why Centaur.AI

We deliver unmatched accuracy, speed, and scalability—helping you ship better AI, faster.

Speed and scale

Access millions of annotations weekly from a network of thousands of experts, taking models from exploratory analysis to deployment in weeks, not months.

Quality by design

Experience how label quality is built into the Centaur.AI system, with frequent performance measurement and pay-for-performance incentives.

Advanced dataset insights

Leverage more reliable statistical information to inform your algorithm training plan.

Privacy and security

Worry less with leading privacy and security capabilities.

Quality focused

Lean on Centaur.AI's expertise as the premier annotation company leveraging collective intelligence to ensure quality.

All data types

From individual types to multimodal solutions, get all of your annotation needs in one single platform.

Accelerate your AI development today.